Acadia Healthcare Company, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $3.3B | $3.2B | $2.9B | $2.6B | $2.3B |
| Pretax income | -$1.1B | $341.9M | -$25.4M | $374.1M | $275.8M |
| Income tax expense | $26.0M | $77.4M | -$9.7M | $94.1M | $67.6M |
| Net income | -$1.1B | $255.6M | -$21.7M | $273.1M | $190.6M |
| Balance Sheet | |||||
| Cash and equivalents | $133.2M | $76.3M | $100.1M | $97.6M | $133.8M |
| Current assets | $814.1M | $577.5M | $596.0M | $506.1M | $495.0M |
| Total assets | $5.5B | $6.0B | $5.4B | $5.0B | $4.8B |
| Current liabilities | $525.2M | $577.9M | $885.8M | $388.3M | $404.9M |
| Total liabilities | $3.4B | $2.8B | $2.5B | $2.1B | $2.2B |
| Total debt | $2.5B | $2.0B | $1.4B | $1.4B | $1.5B |
| Stockholders' equity | $1.9B | $3.1B | $2.8B | $2.8B | $2.5B |
| Cash Flow Statement | |||||
| Cash from operations | $131.9M | $129.7M | $462.3M | $380.6M | $374.5M |
| Depreciation and amortization | $189.2M | $149.6M | $132.3M | $117.8M | $106.7M |
| Stock-based compensation | $31.7M | $37.1M | $32.3M | $29.6M | $37.5M |
| Capital expenditure | $571.8M | $690.4M | $424.1M | $296.1M | $244.8M |
| Free cash flow | -$439.9M | -$560.7M | $38.2M | $84.4M | $129.7M |
| Share repurchases | $50.0M | — | — | — | — |
| Impairments | $1.0B | $17.3M | $9.8M | — | $24.3M |
Shares outstanding 92.2M · Free float 87.4%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.